Day 1Agenda OPTIMUNISE Stakeholders Conference The Proposed INDEPTH Strategic Plan, 2017-20210NSE-stakeholder-optimunise-overview-final1HDSS_Sites2WHO SAGE recommendations on NSE3Non-specific effects of vaccines NSE-stakeholder-non-specific effects ofvaccines4Non-specific immunological effects of vaccines5Randomised trials of BCG to low-birth-weight children in Guinea-Bissau, (Christine Benn) , The age of BCG vaccination and the decline in neonatal mortality: Evidence from Navrongo, Paul Welaga6Optimising the impact of BCG on neonatal mortality7The role of measles vaccine (MV) in reaching MDG48Effects and cost-effectiveness of Measles vaccination campaigns Evidence from Bandim Health Project9OPV campaigns – their role in reaching MDG4: Bandim and Navrongo10Preliminary data from randomised trials 11Sex-differential effects of vaccines:Evidence from Bandim and Nouna12Vitamin A Supplementation Contradicting single effect interventions13The RTS,S vaccine trials: further evidence for NSE or other explanations? 14OPTIMUNISE Lessons learnt15Group work summary DETAILS Website: Previous Post INDEPTH Standardized Verbal Autopsy questionnaire Next Post OpenHDS workshop
Call us:(+233)0244806015 
Email 
